Medtronic Inc (MDT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 01-2026 | 10-2025 | 07-2025 | 04-2025 | 01-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,578,000 | 2,428,000 | 1,047,000 | 4,691,000 | 3,630,000 |
| Depreciation Amortization | 2,242,000 | 1,493,000 | 748,000 | 2,861,000 | 2,021,000 |
| Income taxes - deferred | 59,000 | 160,000 | 167,000 | -316,000 | -81,000 |
| Accounts receivable | 87,000 | 74,000 | 288,000 | -433,000 | -184,000 |
| Other Working Capital | -1,867,000 | -2,569,000 | -1,147,000 | -1,054,000 | -1,504,000 |
| Other Operating Activity | 658,000 | 427,000 | -15,000 | 1,295,000 | 634,000 |
| Operating Cash Flow | $4,757,000 | $2,013,000 | $1,088,000 | $7,044,000 | $4,516,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -590,000 | -243,000 | -90,000 | 269,000 | 162,000 |
| PPE Investments | -1,416,000 | -972,000 | -504,000 | -1,859,000 | -1,400,000 |
| Net Acquisitions | N/A | N/A | N/A | -98,000 | -98,000 |
| Other Investing Activity | -11,000 | 14,000 | -125,000 | -249,000 | -111,000 |
| Investing Cash Flow | $-2,017,000 | $-1,201,000 | $-719,000 | $-1,937,000 | $-1,447,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 173,000 | 1,402,000 | 649,000 | -1,070,000 | -1,070,000 |
| Debt Issued | 1,747,000 | 1,747,000 | 0 | 3,209,000 | 3,209,000 |
| Debt Repayment | -2,930,000 | -2,930,000 | -1,162,000 | N/A | 0 |
| Common Stock Issued | 419,000 | 255,000 | 95,000 | 508,000 | 400,000 |
| Common Stock Repurchased | -600,000 | -495,000 | -123,000 | -3,235,000 | -2,961,000 |
| Dividend Paid | -2,731,000 | -1,820,000 | -910,000 | -3,589,000 | -2,692,000 |
| Other Financing Activity | 59,000 | 65,000 | 70,000 | -184,000 | 96,000 |
| Financing Cash Flow | $-3,863,000 | $-1,776,000 | $-1,381,000 | $-4,361,000 | $-3,018,000 |
| Exchange Rate Effect | 52,000 | 28,000 | 67,000 | 188,000 | -95,000 |
| Beginning Cash Position | 2,218,000 | 2,218,000 | 2,218,000 | 1,284,000 | 1,284,000 |
| End Cash Position | 1,147,000 | 1,282,000 | 1,273,000 | 2,218,000 | 1,240,000 |
| Net Cash Flow | $-1,072,000 | $-936,000 | $-945,000 | $934,000 | $-44,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,757,000 | 2,013,000 | 1,088,000 | 7,044,000 | 4,516,000 |
| Capital Expenditure | -1,416,000 | -972,000 | -504,000 | -1,859,000 | -1,400,000 |
| Free Cash Flow | 3,341,000 | 1,041,000 | 584,000 | 5,185,000 | 3,116,000 |